SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-237718
Filing Date
2019-09-04
Accepted
2019-09-04 16:16:02
Documents
14
Period of Report
2019-08-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d790354d8k.htm   iXBRL 8-K 31680
2 EX-99.1 d790354dex991.htm EX-99.1 12762
6 GRAPHIC g790354g0904102246212.jpg GRAPHIC 2511
  Complete submission text file 0001193125-19-237718.txt   174622

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA epzm-20190829.xsd EX-101.SCH 3066
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20190829_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20190829_pre.xml EX-101.PRE 10950
12 EXTRACTED XBRL INSTANCE DOCUMENT d790354d8k_htm.xml XML 3218
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35945 | Film No.: 191074728
SIC: 2834 Pharmaceutical Preparations